(Q34967200)

5 August 2017

1 reference

title

The economic costs of early stage prostate cancer (English)

1 reference

5 August 2017

1 reference

1

Christopher S Saigal

1 reference

5 August 2017

2

Mark S Litwin

1 reference

5 August 2017

1 January 2002

1 reference

5 August 2017

1 reference

5 August 2017

20

1 reference

5 August 2017

13

1 reference

5 August 2017

869-878

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-200220130-00001

5 August 2017

0 references

cites work

Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer.

1 reference

12 December 2020

When is bone scintigraphy necessary in the assessment of newly diagnosed, untreated prostate cancer?

1 reference

12 December 2020

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

12 December 2020

Physician resource utilization in radiation oncology: a model based on management of carcinoma of the prostate

1 reference

12 December 2020

Screening for prostate cancer. The challenge of promoting informed decision making in the absence of definitive evidence of effectiveness

1 reference

12 December 2020

The Use of Prostate Specific Antigen for Prostate Cancer Screening: A Managed Care Perspective

1 reference

12 December 2020

Changes in prostate cancer incidence and treatment in USA

1 reference

12 December 2020

A nationwide charge comparison of the principal treatments for early stage prostate carcinoma

1 reference

12 December 2020

Charge and length of hospital stay analysis of radical retropubic prostatectomy and transperineal prostate brachytherapy

1 reference

12 December 2020

Unanswered questions in screening for prostate cancer

1 reference

12 December 2020

Practice trends in the diagnosis and management of prostate cancer in the United States

1 reference

12 December 2020

Prostate cancer screening: what we know and what we need to know.

1 reference

12 December 2020

Same day surgery for radical retropubic prostatectomy: is it an attainable goal?

1 reference

12 December 2020

Patient satisfaction with short stays for radical prostatectomy

1 reference

12 December 2020

Epidemiological trends and financial outcomes in radical prostatectomy among Medicare beneficiaries, 1991 to 1993.

1 reference

12 December 2020

Prostate cancer screening: current trends and future implications

1 reference

12 December 2020

Autologous blood donation prior to anatomical radical retropubic prostatectomy: is it necessary?

1 reference

12 December 2020

Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer?

1 reference

12 December 2020

Results of 3D conformal radiotherapy in the treatment of localized prostate cancer

1 reference

12 December 2020

The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population based analysis

1 reference

12 December 2020

The Prostate Cancer Intervention Versus Observation Trial (PIVOT).

1 reference

12 December 2020

Laparoscopic radical prostatectomy: initial short-term experience

1 reference

12 December 2020

Using prostate-specific antigen to eliminate unnecessary diagnostic tests: significant worldwide economic implications

1 reference

12 December 2020

Costs and benefits of early detection of prostatic cancer

1 reference

12 December 2020

The cost of prostatic cancer in a defined population

1 reference

12 December 2020

The benefit and cost of prostate cancer early detection. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project

1 reference

12 December 2020

Laparoscopic radical prostatectomy: assessment after 240 procedures

1 reference

12 December 2020

The economics of prostate cancer screening

1 reference

12 December 2020

Three-dimensional treatment planning and conformal radiation therapy: preliminary evaluation

1 reference

12 December 2020

Update on the appropriate staging evaluation for newly diagnosed prostate cancer

1 reference

12 December 2020

Open pelvic lymph node dissection for prostate cancer: a reassessment.

1 reference

12 December 2020

The growing importance of cost-effectiveness in oncologic practice

1 reference

12 December 2020

Commentary: quality of care and cost containment are the hospital-based ambulatory surgery challenges for the future

1 reference

12 December 2020

Cost comparison of radical prostatectomy and transperineal brachytherapy for localized prostate cancer

1 reference

12 December 2020

Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE database

1 reference

12 December 2020

Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer

1 reference

12 December 2020

The need for hospital care of patients with clinically localized prostate cancer managed by noncurative intent: a population based registry study

1 reference

12 December 2020

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

1 reference

12 December 2020

Echogenic structure of prostatic cancer imaged on radical prostatectomy specimens

1 reference

12 December 2020

Economics of screening for carcinoma of the prostate

1 reference

12 December 2020

Cost-efficient radical prostatectomy with a clinical care path.

1 reference

12 December 2020

The cost effectiveness of 3D conformal radiation therapy compared with conventional techniques for patients with clinically localized prostate cancer

1 reference

12 December 2020

The economic burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model

1 reference

12 December 2020

Cost-effectiveness comparison of estrogen therapy and orchidectomy in patients with prostatic cancer.

1 reference

12 December 2020

1 reference

12 December 2020

HMO membership, treatment, and mortality risk among prostatic cancer patients

1 reference

12 December 2020

Using PSA to eliminate the staging radionuclide bone scan. Significant economic implications

1 reference

12 December 2020

The role of active treatment in early prostate cancer

1 reference

12 December 2020

Limited efficacy of preoperative computed tomographic scanning for the evaluation of lymph node metastasis in patients before radical prostatectomy

1 reference

12 December 2020

Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care

1 reference

12 December 2020

Urologists on a tightrope: coping with a changing economy.

1 reference

12 December 2020

Maintaining quality of care and patient satisfaction with radical prostatectomy in the era of cost containment

1 reference

12 December 2020

The dilemma of prostate cancer--a growing human and economic burden irrespective of treatment strategies

1 reference

12 December 2020

The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection

1 reference

12 December 2020

10.2165/00019053-200220130-00001

Identifiers

DOI

1 reference

PubMed ID

12381239

Dimensions Publication ID

5 August 2017

0 references

1 reference

PubMed ID

12381239